Page last updated: 2024-09-03

thrombin receptor peptide sfllrnp and ozagrel

thrombin receptor peptide sfllrnp has been researched along with ozagrel in 1 studies

Compound Research Comparison

Studies
(thrombin receptor peptide sfllrnp)
Trials
(thrombin receptor peptide sfllrnp)
Recent Studies (post-2010)
(thrombin receptor peptide sfllrnp)
Studies
(ozagrel)
Trials
(ozagrel)
Recent Studies (post-2010) (ozagrel)
9210295293137

Protein Interaction Comparison

ProteinTaxonomythrombin receptor peptide sfllrnp (IC50)ozagrel (IC50)
cystic fibrosis transmembrane conductance regulatorHomo sapiens (human)3.43
Thromboxane-A synthase Homo sapiens (human)0.0864
Thromboxane-A synthaseRattus norvegicus (Norway rat)0.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Derkach, DN; Hirano, K; Ihara, E; Kanaide, H; Nishimura, J; Takahashi, S1

Other Studies

1 other study(ies) available for thrombin receptor peptide sfllrnp and ozagrel

ArticleYear
Thrombin causes endothelium-dependent biphasic regulation of vascular tone in the porcine renal interlobar artery.
    British journal of pharmacology, 2000, Volume: 131, Issue:8

    Topics: Animals; Biological Factors; Calcium; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Methacrylates; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Phenylephrine; Potassium; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Renal Artery; Swine; Thrombin; Thromboxane A2; Thromboxane-A Synthase; Vasoconstriction; Vasoconstrictor Agents; Vasodilation

2000